• Morphotek inks license deal with BlissBio biospectrumasia
    April 11, 2018
    BlissBio has an exclusivity option to expand the territory beyond China to the global market and to develop therapeutic ADCs to two additional undisclosed oncology targets.
PharmaSources Customer Service